Daniel Edwin Singer

Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention.

Lopes RD, Atlas SJ, Go AS, Lubitz SA, McManus DD, Dolor RJ, Chatterjee R, Rothberg MB, Rushlow DR, Crosson LA, Aronson RS, Patlakh M, Gallup D, Mills DJ, O'Brien EC, Singer DE.

J Am Coll Cardiol. 2024 Aug 29. PMID: 39230544

Identifying a Heterogeneous Effect of Atrial Fibrillation Screening in Older Adults: A Secondary Analysis of the VITAL-AF Trial.

Shah SJ, Iyer JM, Agha L, Chang Y, Ashburner JM, Atlas SJ, McManus DD, Ellinor PT, Lubitz SA, Singer DE.

medRxiv. 2024 Aug 28. PMID: 38883753

Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.

Simon TG, Singer DE, Zhang Y, Mastrorilli JM, Cervone A, DiCesare E, Lin KJ.

Ann Intern Med. 2024 Aug. 177(8):1028-1038. PMID: 38976880

Letter by Ko et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".

Ko D, Kim DH, Singer DE.

Circulation. 2024 Jul 09. 150(2):e25-e26. PMID: 38976608

Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis.

Harrington J, Hellkamp AS, Mahaffey KW, Breithardt G, Halperin JL, Hankey GJ, Becker RC, Nessel CC, Berkowitz SD, Fox KAA, Singer DE, Goodman SG, Patel MR, Piccini JP.

J Am Heart Assoc. 2024 Jun 04. 13(11):e028951. PMID: 38780169

Automated interpretations of single-lead electrocardiograms predict incident atrial fibrillation: The VITAL-AF trial.

Pipilas DC, Khurshid S, Al-Alusi MA, Atlas SJ, Ashburner JM, Borowsky LH, McManus DD, Singer DE, Lubitz SA, Chang Y, Ellinor PT.

Heart Rhythm. 2024 Sep. 21(9):1640-1646. PMID: 38692342

Predicting post-stroke cognitive impairment using electronic health record data.

Ashburner JM, Chang Y, Porneala B, Singh SD, Yechoor N, Rosand JM, Singer DE, Anderson CD, Atlas SJ.

Int J Stroke. 2024 Oct. 19(8):898-906. PMID: 38546170

Development and Validation of an Intracranial Hemorrhage Risk Score in Older Adults with Atrial Fibrillation Treated with Oral Anticoagulant.

Bessette LG, Singer DE, Pawar A, Wong V, Kim DH, Lin KJ.

Clin Epidemiol. 2024. 16:267-279. PMID: 38645475

Healthcare Resource Utilization Following Single-lead Electrocardiogram Screening for Atrial Fibrillation in Older Individuals at Primary Care Visits.

Atlas SJ, Borowsky LH, Chang Y, Ashburner JM, Ellinor PT, Lubitz SA, Singer DE.

J Gen Intern Med. 2024 Aug. 39(11):2120-2122. PMID: 38565766

Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials.

Shah SJ, van Walraven C, Jeon SY, Boscardin J, Hobbs FDR, Connolly SJ, Ezekowitz MD, Covinsky KE, Fang MC, Singer DE.

Circ Cardiovasc Qual Outcomes. 2024 Apr. 17(4):e010269. PMID: 38525596